| Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (NCT00351169) | AstraZeneca | 2006-05-01 |
| Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome (NCT01035073) | University of Pennsylvania | 2006-04-01 |
| Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders (NCT00326105) | AstraZeneca | 2006-04-01 |
| Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment (NCT01876823) | New York State Psychiatric Institute | 2006-04-01 |
| Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder (NCT00320268) | AstraZeneca | 2006-04-01 |
| Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders (NCT00326144) | AstraZeneca | 2006-04-01 |
| Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder (NCT00321490) | AstraZeneca | 2006-04-01 |
| Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder (NCT00733668) | AstraZeneca | 2006-03-01 |
| Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder (NCT00277823) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-02-01 |
| Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression (NCT01198561) | Samsung Medical Center | 2006-02-01 |
| EEG Biomarkers for Predicting Response to Antidepressant Therapy (NCT00289523) | Medtronic - MITG | 2006-01-01 |
| Treatment-Resistant Depression Registry (NCT00320372) | Cyberonics, Inc. | 2006-01-01 |
| Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder (NCT00278941) | AstraZeneca | 2005-12-01 |
| Memory Functioning and Antidepressant Treatment (NCT00296933) | University Health Network, Toronto | 2005-12-01 |
| Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder (NCT00135421) | Bristol-Myers Squibb | 2005-11-01 |
| Biological Markers of Response to Treatment in Major Depressive Disorder (NCT00361218) | Massachusetts General Hospital | 2005-10-01 |
| Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression (NCT00608543) | University of Texas Southwestern Medical Center | 2005-10-01 |
| Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (NCT00252356) | Sanofi | 2005-09-01 |
| Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder (NCT01148472) | H. Lundbeck A/S | 2005-09-01 |
| Investigation of a Combination Treatment of Escitalopram and rTMS (NCT00232700) | Charite University, Berlin, Germany | 2005-09-01 |
| Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (NCT00252330) | Sanofi | 2005-09-01 |
| Wellbutrin XL, Major Depressive Disorder and Breast Cancer (NCT00234195) | Thomas Jefferson University | 2005-09-01 |
| The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression (NCT00125957) | Mclean Hospital | 2005-08-01 |
| An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression (NCT00128505) | Corcept Therapeutics | 2005-08-01 |
| Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression (NCT00215228) | Duke University | 2005-07-01 |
| An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression (NCT00146523) | Corcept Therapeutics | 2005-05-01 |
| The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity (NCT00205946) | Affective Neuroscience Laboratory | 2005-04-01 |
| Effects of Early Abuse on Adult Intimate Relationships (NCT01803802) | University of Texas at Austin | 2005-04-01 |
| Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation (NCT00305045) | Centre for Addiction and Mental Health | 2005-03-01 |
| The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder (NCT00107120) | Forest Laboratories | 2005-03-01 |
| A Study of Aripiprazole in Patients With Major Depressive Disorder (NCT00105196) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2005-03-01 |
| Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder (NCT00262665) | Dennis Charney | 2005-03-01 |
| Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials (NCT00191594) | Eli Lilly and Company | 2005-03-01 |
| Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder (NCT00239954) | Pharmacology Research Institute | 2005-03-01 |
| Abilify Therapy for Reducing Comorbid Substance Abuse (NCT00208169) | Creighton University | 2005-03-01 |
| Study of Escitalopram in Adult Patients With Major Depressive Disorder (NCT00108979) | Forest Laboratories | 2005-03-01 |
| Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients (NCT00166296) | Germans Trias i Pujol Hospital | 2005-03-01 |
| Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder (NCT00109044) | Forest Laboratories | 2005-03-01 |
| Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder (NCT00593879) | Targacept Inc. | 2005-02-01 |
| A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder (NCT00188942) | University Health Network, Toronto | 2005-02-01 |
| Assessment of Cognitive Functioning Before and After Treatment With Duloxetine (NCT00933439) | University of Texas Southwestern Medical Center | 2005-02-01 |
| Characterizing Psychological Consequences of Childhood Trauma (NCT00209105) | Emory University | 2005-01-01 |
| Deep Brain Stimulation in Treatment Refractory Depression (NCT01921543) | Universitaire Ziekenhuizen KU Leuven | 2005-01-01 |
| The Effect of Fish Oil in Major Depressive Disorder (NCT00816322) | National Science and Technology Council, Taiwan | 2005-01-01 |
| Magnetic Resonance Imaging Study of Geriatric Depression (NCT00245557) | Mclean Hospital | 2004-11-01 |
| Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder (NCT00242229) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-10-01 |
| Light Therapy for Depression During Pregnancy (NCT01043289) | Psychiatric Hospital of the University of Basel | 2004-10-01 |
| Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse (NCT00108407) | US Department of Veterans Affairs | 2004-10-01 |
| Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy (NCT00095134) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-10-01 |
| Safety Study of ORG 34517 for Major Depression With Psychotic Features (NCT00226278) | Weill Medical College of Cornell University | 2004-09-01 |
| A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder (NCT00095745) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-09-01 |
| A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder (NCT00095758) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-09-01 |
| A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression (NCT00128479) | Corcept Therapeutics | 2004-09-01 |
| A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression (NCT00130676) | Corcept Therapeutics | 2004-09-01 |
| Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) (NCT00479726) | Eli Lilly and Company | 2004-08-01 |
| Switching to Duloxetine From Other Antidepressants (NCT00191932) | Eli Lilly and Company | 2004-08-01 |
| A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder (NCT00168376) | The Alfred | 2004-07-01 |
| Treatment of Nicotine Dependence and Acute Depression (NCT00186446) | Stanford University | 2004-06-01 |
| Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome (NCT00149825) | Stanford University | 2004-06-01 |
| A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder (NCT00095823) | Bristol-Myers Squibb | 2004-06-01 |
| Priming rTMS In Major Depression (NCT00168272) | The Alfred | 2004-06-01 |
| The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram (NCT00179257) | Vanderbilt University | 2004-06-01 |
| Treatment for Chronic Depression (NCT00204152) | University of Chicago | 2004-06-01 |
| Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response (NCT00188396) | University Health Network, Toronto | 2004-04-01 |
| Behavioral Processes Underlying Reward Processing in Depression (NCT00205933) | Affective Neuroscience Laboratory | 2004-04-01 |
| Fibromyalgia in Men Suffering From PTSD (NCT00229294) | Sheba Medical Center | 2004-03-01 |
| Patient-Centered Depression Care for African Americans (NCT00243425) | Agency for Healthcare Research and Quality (AHRQ) | 2004-03-01 |
| Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse (NCT00223197) | University of Texas Southwestern Medical Center | 2004-02-01 |
| FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression (NCT00075296) | National Institute of Mental Health (NIMH) | 2004-01-05 |
| Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder (NCT00104611) | Neuronetics | 2004-01-01 |
| Duloxetine Versus Paroxetine for Major Depression (NCT00489775) | Eli Lilly and Company | 2004-01-01 |
| Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder (NCT00452595) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-01-01 |
| Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder (NCT01309542) | Pfizer | 2003-08-01 |
| A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid Recipients (NCT00373477) | University of North Carolina | 2003-07-01 |
| Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression (NCT00744406) | Centre for Addiction and Mental Health | 2003-07-01 |
| Brain Regulation of Emotions in People With Depression and Anhedonia (NCT00059579) | National Institute of Mental Health (NIMH) | 2003-04-24 |
| Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression (NCT00157547) | Massachusetts General Hospital | 2003-04-01 |
| A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. (NCT00335205) | Sheba Medical Center | 2003-04-01 |
| Light Therapy for Elderly Depression (NCT00332670) | GGZ Buitenamstel | 2003-01-01 |
| Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression (NCT00042562) | Eli Lilly and Company | 2002-12-01 |
| Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder (NCT00931775) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2002-12-01 |
| Electroencephalography (EEG) Biomarkers of Response in Depression (NCT00759122) | University of California, Los Angeles | 2002-11-01 |
| Major Depressive Disorder Study In Adults (NCT00049972) | GlaxoSmithKline | 2002-09-01 |
| eCare for Moods: An Internet-based Management Program (NCT00485420) | Kaiser Permanente | 2002-09-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) (NCT00048607) | Merck Sharp & Dohme LLC | 2002-07-30 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders (NCT00182533) | Hamilton Health Sciences Corporation | 2002-07-01 |
| Brain Imaging Techniques That Predict Antidepressant Responsiveness (NCT00909155) | University of Wisconsin, Madison | 2002-07-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073) (NCT00042029) | Merck Sharp & Dohme LLC | 2002-06-18 |
| Deep Brain Stimulation for Refractory Major Depression (NCT00296920) | University Health Network, Toronto | 2002-06-01 |
| Cognitive Behavioral Therapy for Early-Onset Depression (NCT00096642) | Centre for Addiction and Mental Health | 2002-06-01 |
| Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression (NCT00042575) | Eli Lilly and Company | 2002-06-01 |
| The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression (NCT00035321) | Eli Lilly and Company | 2002-04-01 |
| Magnetic Seizure Therapy (MST) for the Treatment of Major Depression (NCT00973934) | Sarah Lisanby | 2002-04-01 |
| Sertraline vs. Venlafaxine XR (NCT00179283) | Vanderbilt University | 2002-04-01 |
| Depression, Epinephrine, and Platelet Function (NCT00166114) | Emory University | 2002-02-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063) (NCT00034944) | Merck Sharp & Dohme LLC | 2002-01-24 |
| Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) (NCT00048594) | Merck Sharp & Dohme LLC | 2002-01-03 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED) (NCT00035048) | Merck Sharp & Dohme LLC | 2001-11-21 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) (NCT00035295) | Merck Sharp & Dohme LLC | 2001-11-08 |
| Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder (NCT00025974) | National Institute of Mental Health (NIMH) | 2001-10-31 |